PlainRecalls

Nostrum Laboratories, Inc.

Compiled from official public sources by the publisher.

8 recalls on record · Latest: Aug 6, 2025

Subscribe to new Nostrum Laboratories, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Nostrum Laboratories, Inc. LIGHT-BOOK · SINGLE-AGENCY

#1,778 of 14,151 · 8 notices · 0.008% archive

  • BOOK 8 notices
  • RANK #1,778 of 14,151
  • SHARE 0.008% archive
  • AGENCY FDA Drug (8)
  • CAT children
  • CATS 3 categories
  • LATEST Aug 6, 2025
  • PHOTO Ab Sciex

Nearest notice-volume peer: Ab Sciex (0 notice gap)

Nostrum Laboratories, Inc. accounts for about 0.008% of the 104,423-notice archive on 8 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Nostrum Laboratories, Inc. compares to 14,151 recalling firms

Nostrum Laboratories, Inc. ranks 1,778th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Nostrum Laboratories, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

8 1778th of 14151 higher than 12,296 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Nostrum Laboratories, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Nostrum Laboratories, Inc. holds about 0.008% of archive notices alongside 8 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Aug 6, 2025

Sucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003-01, and b) 500-count bottles, NDC 29033-0003-05), Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120.
FDA Drug Moderate Feb 10, 2021

Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120. NDC: 29033-056-01
FDA Drug Moderate Jan 20, 2021

Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 tablets per bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC: 29033-056-01
FDA Drug Moderate Nov 11, 2020

Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, Rx Only. Manufactured by: Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-055-01
FDA Drug Moderate Nov 11, 2020

Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count bottles, Rx Only. Manufactured by: Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-056-01
FDA Drug Moderate Apr 1, 2020

Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.
FDA Drug Low Feb 28, 2018

Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02
FDA Drug Moderate Jun 22, 2016

Nitrofurantoin Oral Suspension, USP, 25 mg/5 mL, FOR ORAL USE ONLY, URINARY TRACT ANTIBACTERIAL, Rx Only , 240 mL bottle, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Mfg. by: Sun Pharmaceutical Industries, Inc., Bryan, Ohio 43506, NDC 57664-239-32

Nostrum Laboratories, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (8 here).

Ab Sciex 8 Acumedia Manufacturers, Inc. 8 Adept Medical Ltd 8 Aju Pharm Co., Ltd. 8 Ambriola Co., Inc., The 8

Similar children volume

Nearest multi-notice firms that share this firm's dominant product category.

Anabolic Science Labs, LLC 8 Beaumont Bio-med, Inc. 8 Garden Of Life Llc 8 Infantino LLC, of San Diego, Calif. 8

Frequently Asked Questions

How many federal recall notices name Nostrum Laboratories, Inc.? ▼
PlainRecalls indexes 8 distinct federal recall events naming Nostrum Laboratories, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Nostrum Laboratories, Inc. sit among other recalling firms? ▼
Nostrum Laboratories, Inc. ranks #1,778 of 14,151 by distinct recall-event count among 14,151 firms in this archive (87th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Nostrum Laboratories, Inc.'s notices? ▼
FDA Drug accounts for 8 of this firm's 8 indexed notices.
What product category dominates Nostrum Laboratories, Inc.'s filing book? ▼
Filings for Nostrum Laboratories, Inc. span 3 product categories, led by children. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Nostrum Laboratories, Inc.: 8 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Nostrum Laboratories, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026